Foresite Capital Fund III L.P. 13D and 13G filings for CymaBay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-02-16 10:41 am Sale |
2020-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
Foresite Capital Fund III L.P. | 3,428,898 5.000% |
-390,828![]() (-10.23%) |
Filing |